Krebs Andreas
SEC CIK 1438946 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DFTX | Definium Therapeutics, Inc. | Dir | 21.4K | — | — | 5 | 2022-06-01 | 2026-09-18 |
Most active insiders at DFTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barrow Robert | CEO, Dir | — | $3.08M |
| 2 | Sullivan Mark | CLO | — | $1.04M |
| 3 | Karlin Daniel | Chief Medical Off | — | $748.9K |
| 4 | Roberts Brandi | CFO | — | $135.7K |
| 5 | Wiley Matthew T. | Chief Commercial Off | — | $129.1K |
| 6 | Adsett Roger | Dir | — | — |
| 7 | CRYSTAL ROGER | Dir | — | — |
| 8 | Bruhn Suzanne Louise | Dir | — | — |
| 9 | Krebs Andreas | Dir | — | — |
| 10 | Vallone Carol A | Dir | — | — |
Transactions 5
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-18 21:55 | 2026-09-18 | DFTX | Definium Therapeutics, Inc. | Krebs Andreas | Dir | M - OptEx | $35.52 | +1,629 | 21.4K | +8% | +$57.9K |
| D | 2026-06-15 16:30 | 2026-06-11 | DFTX | Definium Therapeutics, Inc. | Krebs Andreas | Dir | A - Grant | $0.00 | +4,666 | 19.8K | +31% | $0 |
| D | 2023-06-23 | 2023-06-21 | DFTX | Definium Therapeutics, Inc. | Krebs Andreas | Dir | A - Grant | $0.00 | +13.7K | 15.1K | +952% | $0 |
| DA | 2022-06-06 | 2022-06-01 | DFTX | Definium Therapeutics, Inc. | Krebs Andreas | Dir | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
| D | 2022-06-03 | 2022-06-01 | DFTX | Definium Therapeutics, Inc. | Krebs Andreas | Dir | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations